CMBA
EW icon

C.M. Bidwell & Associates’s Edwards Lifesciences EW Stock Holding History

C.M. Bidwell & Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,215
Closed -$92.6K – 498
2023
Q4 		$92.6K Buy
+1,215
New +$84.5K 0.07% 168
2017
Q4 		– Sell
-4,365
Closed -$159K – 412
2017
Q3 		$159K Buy
+4,365
New +$166K 0.24% 147
2016
Q3 		– Sell
-130,155
Closed -$4.33M – 280
2016
Q2 		$4.33M Sell
130,155
-315
-0.2% -$10.8K 1.07% 22
2016
Q1 		$3.84M Buy
+130,470
New +$3.6M 0.96% 37

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

C.M. Bidwell & Associates's EW Position: Q1 2024 in Review

C.M. Bidwell & Associates sold out of Edwards Lifesciences (EW) in Q1 2024, closing a stake of 1,215 shares — an estimated $92.6K sold.

C.M. Bidwell & Associates first reported a position in EW in Q1 2016 and held it in 4 quarters. The position peaked at $4.33M in Q2 2016. 1,281 funds tracked by Wall St. Rank hold EW as of Q1 2024.

  • C.M. Bidwell & Associates reported no remaining Edwards Lifesciences position as of Q1 2024 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 1,215 Edwards Lifesciences shares in Q1 2024, an estimated $92.6K.
  • C.M. Bidwell & Associates first reported a position in Edwards Lifesciences in Q1 2016 and held it in 4 quarters.
  • C.M. Bidwell & Associates's Edwards Lifesciences position peaked at $4.33M in Q2 2016.
  • 1,281 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2024.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2024, filed 14 May 2024.